Enabling proteomics-based identification of human cancer variations
['Jing Li', 'Zeqiang Ma', 'Robbert J.C. Slebos', 'David L. Tabb', 'Daniel C. Liebler', 'Bing Zhang']
Enabling proteomics-based identification of human cancer variations